Practical prevention and treatment of cardiovascular diseases in patients with diabetes mellitus type 2 in an endocrinological department

• Published in: Terapevtic̆eskii arhiv Vol. 76; no. 12; p. 32
• Main Authors: Daurbekova, L V, Orlov, V A, Giliarevskiĭ, S R, Abirova, E S, Murzabekova, L I
• Format: Journal Article
• Language: Russian
• Published: Russia (Federation) 2004
• Subjects: Angiotensin-Converting Enzyme Inhibitors - administration & dosage; Aspirin - administration & dosage; Cardiovascular Diseases - complications; Cardiovascular Diseases - prevention & control; Diabetes Mellitus, Type 2 - complications; Endocrinology; Hospital Departments; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors - administration & dosage; Platelet Aggregation Inhibitors - administration & dosage
• ISSN: 0040-3660

To analyse retrospectively quality of medical correction of modified risk factors (RF) and treatment of cardiovascular diseases (CVD) in patients with diabetes mellitus type (DM) 2 admitted to specialized endocrinological departments. Analysis of medication policy of CVD RF was made retrospectively for 250 patients treated in endocrinological departments of Moscow hospital in 2003. Arterial hypertension, coronary heart disease were diagnosed in 93.2 and 87.2% examinees. History of myocardial infarction and brain stroke was in 8.4 and 6% patients. Statins were prescribed in 2.4% cases. Examination for dyslipidemia was not satisfactory. ACE inhibitors were prescribed in 71.2% patients. Aspirin was prescribed (18%) primarily by the cardiologist. Quality of medical prophylaxis of CVD RF in DM type 2 patients in the departments does not satisfy modern clinical recommendations.